Open AccessEffect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy
Author(s) -
Zaid Bilgrami,
Ameer Abutaleb,
Kenechukwu Chudy-Onwugaje,
Patricia Langenberg,
Miguel Regueiro,
David A. Schwartz,
J. Kathleen Tracy,
Leyla Ghazi,
Seema Patil,
Sandra Quezada,
Katharine Russman,
Charlene C. Quinn,
Guruprasad Jambaulikar,
Dawn B. Beaulieu,
Sara Horst,
Raymond K. Cross
Publication year - 2019
Publication title -
digestive diseases and sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 124
eISSN - 1573-2568
pISSN - 0163-2116
DOI - 10.1007/s10620-018-5433-5
Subject(s) - medicine , telemedicine , randomized controlled trial , inflammatory bowel disease , hepatology , physical therapy , disease , health care , economics , economic growth
Limitations in inflammatory bowel disease (IBD) care necessitate greater patient activation and self-efficacy, measures associated with positive health outcomes.